| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2014 | US20140105983 Pulmonary Delivery for Levodopa |
| 04/17/2014 | US20140105979 Compositions and methods for the transdermal delivery of methylphenidate |
| 04/17/2014 | US20140105978 Silk microspheres for encapsulation and controlled release |
| 04/17/2014 | US20140105977 Gastric retentive extended release pharmaceutical compositions |
| 04/17/2014 | US20140105976 Pharmaceutical formulations of pilocarpine |
| 04/17/2014 | US20140105973 Method of treating a disease condition susceptible to baclofen therapy |
| 04/17/2014 | US20140105969 Compositions and Methods for Treating Cancer |
| 04/17/2014 | US20140105967 Stabilized composition and method for dermatological treatment |
| 04/17/2014 | US20140105959 Method and device for reducing dermal filler adverse events |
| 04/17/2014 | US20140105956 Biodegradable polymer based microimplant for ocular drug delivery |
| 04/17/2014 | US20140105937 Topical ubiquinol oral supplement compositions with amorphous calcium phosphate |
| 04/17/2014 | US20140105933 Methods for assessing cancer recurrence |
| 04/17/2014 | US20140105932 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof |
| 04/17/2014 | US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis |
| 04/17/2014 | US20140105919 Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancer |
| 04/17/2014 | US20140105911 Method Of Treatment Of Vascular Complications |
| 04/17/2014 | US20140105908 Methods for treating prostate cancer |
| 04/17/2014 | US20140105898 Apoptosis-inducing molecules and uses therefor |
| 04/17/2014 | US20140105895 Treatment of solid tumors with rapamycin derivatives |
| 04/17/2014 | US20140105893 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor |
| 04/17/2014 | US20140105891 Treatment of cancer |
| 04/17/2014 | US20140105884 Material and method for treating internal cavities |
| 04/17/2014 | US20140105879 Flour-based functional food |
| 04/17/2014 | US20140105878 Compositions and methods for prevention and treatment of migraines |
| 04/17/2014 | US20140105877 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 04/17/2014 | US20140105876 Ceramic biocomposite for bone regeneration |
| 04/17/2014 | US20140105864 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 04/17/2014 | US20140105852 Cross-linked polysaccharide composition |
| 04/17/2014 | US20140105851 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders |
| 04/17/2014 | US20140105850 Treatment of multiple sclerosis with laquinimod |
| 04/17/2014 | US20140105848 Potassium binding polymers for treating hypertension and hyperkalemia |
| 04/17/2014 | US20140105830 Abuse-proofed dosage form |
| 04/17/2014 | US20140105829 Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same |
| 04/17/2014 | US20140105824 Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| 04/17/2014 | US20140105818 Novel Vesicles and Nanostructures from Recombinant Proteins |
| 04/17/2014 | DE102012109742A1 Arzneimittel zur Prophylaxe und Behandlung einer neurodegenerativen Erkrankung Medicines for prophylaxis and treatment of a neurodegenerative disease |
| 04/17/2014 | DE102012019194A1 Medizinisches Präparat umfassend einen Träger mit Polyhexanid oder Octenidin Medical preparation comprising a support having Polyhexanide or Octenidine |
| 04/16/2014 | EP2719762A1 Tyrosinase inhibitors for depigmentation or hair removal |
| 04/16/2014 | EP2719700A1 Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
| 04/16/2014 | EP2719699A1 Certain triazolopyrazines, compositions thereof and methods of use therefor |
| 04/16/2014 | EP2719698A1 Methods for preparing aurora kinase inhibitors |
| 04/16/2014 | EP2719697A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof |
| 04/16/2014 | EP2719696A1 Novel kinase inhibitors |
| 04/16/2014 | EP2719691A1 Benzothiazinethione derivatives and their preparative methods and uses |
| 04/16/2014 | EP2719690A1 Amide compound and pharmaceutical application therefor |
| 04/16/2014 | EP2719685A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/16/2014 | EP2719390A1 Carbon-monoxide(co)-assisted inhibition of fatty acid and cholesterol uptake |
| 04/16/2014 | EP2719389A1 Compositions and methods for treating and preventing skeletal muscle deficiencies |
| 04/16/2014 | EP2719388A1 Boron-containing small molecules as anti-inflammatory agents |
| 04/16/2014 | EP2719387A1 Preparation method of flumazenil labeled with fluorine-18 using diaryl iodonium salt precursor |
| 04/16/2014 | EP2719386A1 Pharmaceutical compositions and methods for producing low impurity concentrations of the same |
| 04/16/2014 | EP2719385A1 Method of treating thermoregulatory disfunction with paroxetine |
| 04/16/2014 | EP2719384A1 Novel 1 -naphthyl-3-azabicyclo[3.1.0]hexanes:preparation and use to treat neurophychiatric disorders |
| 04/16/2014 | EP2719383A2 Composition for eyelash growth |
| 04/16/2014 | EP2719382A1 Ethyl Eicosapentanoate and Pharmaceutical Compositions Comprising Ethyl Eicosapentanoate as an Active Ingredient for Use in the Treatment of Non-Alcoholic Steatohepatitis |
| 04/16/2014 | EP2719381A1 Dialysis agent a comprising acetic acid and acetate salt, and two pack type dialysis agent |
| 04/16/2014 | EP2719380A2 SUR1 inhibitors for therapy |
| 04/16/2014 | EP2719379A1 Hydroxytyrosol benefits mitochondria |
| 04/16/2014 | EP2719375A1 Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms |
| 04/16/2014 | EP2719374A1 Drug delivery device |
| 04/16/2014 | EP2719291A1 Dietetic product for long-term administration to patients after bariatric surgery |
| 04/16/2014 | EP2719290A1 A microencapsulated amino acid composition and method of manufacturing microencapsulated amino acid composition |
| 04/16/2014 | EP2719287A1 Compositions for the treatment of hyperlipidemia |
| 04/16/2014 | EP2718436A1 Materials and methods for treating pten mutated or deficient cancer |
| 04/16/2014 | EP2718435A1 Sema5b peptides and vaccines including the same |
| 04/16/2014 | EP2718331A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof |
| 04/16/2014 | EP2718297A2 New taccalonolide microtubule stabilizers |
| 04/16/2014 | EP2718296A1 Synthesis and characterization of second generation benzofuranone ring substituted noscapine analogs |
| 04/16/2014 | EP2718295A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors |
| 04/16/2014 | EP2718293A1 Substituted pyridopyrazines as novel syk inhibitors |
| 04/16/2014 | EP2718292A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom |
| 04/16/2014 | EP2718291A1 Benzoquinolizidine derivatives, method for preparing same, and therapeutic uses thereof |
| 04/16/2014 | EP2718288A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders |
| 04/16/2014 | EP2718287A1 [1,3]oxazines |
| 04/16/2014 | EP2718286A1 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors |
| 04/16/2014 | EP2718285A1 Hydantoin derivates as kv3 inhibitors |
| 04/16/2014 | EP2718284A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS |
| 04/16/2014 | EP2718283A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
| 04/16/2014 | EP2718282A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant |
| 04/16/2014 | EP2718281A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 04/16/2014 | EP2718280A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 04/16/2014 | EP2718279A1 Novel compounds as modulators of gpr-119 |
| 04/16/2014 | EP2718278A1 Compounds as ppar beta/delta inhibitors for treating ppar beta/delta-mediated diseases |
| 04/16/2014 | EP2718276A1 Heterocyclic sulfonamide derivatives |
| 04/16/2014 | EP2718273A1 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid |
| 04/16/2014 | EP2718271A1 Substituted benzamide derivatives |
| 04/16/2014 | EP2718270A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| 04/16/2014 | EP2718269A1 Cleavable lipids |
| 04/16/2014 | EP2718267A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/16/2014 | EP2718266A1 Pyridin- 2 -amides useful as cb2 agonists |
| 04/16/2014 | EP2718264A1 Benzocycloheptene acetic acids |
| 04/16/2014 | EP2718261A2 Compounds for targeting drug delivery and enhancing sirna activity |
| 04/16/2014 | EP2717893A1 Lipid nanoparticle compositions and methods for mrna delivery |
| 04/16/2014 | EP2717891A1 BIXA ORELLANA COMPOSITION FOR TREATING MACULAR DEGENERATION& xA; |
| 04/16/2014 | EP2717886A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism |
| 04/16/2014 | EP2717885A1 Antiinfective composition |
| 04/16/2014 | EP2717884A1 Use of metallocene compounds for cancer treatment |
| 04/16/2014 | EP2717883A1 Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg) |
| 04/16/2014 | EP2717882A1 Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression |
| 04/16/2014 | EP2717881A1 Method of treating dengue fever |